- Home
- PBT vs AMLX Comparison
PBT vs AMLX Comparison
Compare PBT & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- AMLX
- Stock Information
- Founded
- PBT 1980
- AMLX 2014
- Country
- PBT United States
- AMLX United States
- Employees
- PBT N/A
- AMLX N/A
- Industry
- PBT Oil & Gas Production
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- PBT Energy
- AMLX Health Care
- Exchange
- PBT Nasdaq
- AMLX Nasdaq
- Market Cap
- PBT 475.4M
- AMLX 459.1M
- IPO Year
- PBT N/A
- AMLX 2022
- Fundamental
- Price
- PBT $10.52
- AMLX $4.49
- Analyst Decision
- PBT
- AMLX Buy
- Analyst Count
- PBT 0
- AMLX 5
- Target Price
- PBT N/A
- AMLX $9.60
- AVG Volume (30 Days)
- PBT 81.2K
- AMLX 1.0M
- Earning Date
- PBT 01-01-0001
- AMLX 05-08-2025
- Dividend Yield
- PBT 3.94%
- AMLX N/A
- EPS Growth
- PBT N/A
- AMLX N/A
- EPS
- PBT 0.55
- AMLX N/A
- Revenue
- PBT $27,114,144.00
- AMLX N/A
- Revenue This Year
- PBT N/A
- AMLX N/A
- Revenue Next Year
- PBT N/A
- AMLX N/A
- P/E Ratio
- PBT $18.56
- AMLX N/A
- Revenue Growth
- PBT N/A
- AMLX N/A
- 52 Week Low
- PBT $8.01
- AMLX $1.58
- 52 Week High
- PBT $14.26
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- PBT 62.56
- AMLX 49.58
- Support Level
- PBT $9.73
- AMLX $4.41
- Resistance Level
- PBT $10.20
- AMLX $4.95
- Average True Range (ATR)
- PBT 0.34
- AMLX 0.42
- MACD
- PBT 0.07
- AMLX -0.10
- Stochastic Oscillator
- PBT 97.37
- AMLX 16.54
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.